Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report

• Päätekijät: Yoichi Nishii (Tekijä), Kazuki Furuhashi (Tekijä), Kentaro Ito (Tekijä), Tadashi Sakaguchi (Tekijä), Yuta Suzuki (Tekijä), Kentaro Fujiwara (Tekijä), Taro Yasuma (Tekijä), Tetsu Kobayashi (Tekijä), Corina N. D'Alessandro-Gabazza (Tekijä), Esteban C. Gabazza (Tekijä), Osamu Taguchi (Tekijä), Osamu Hataji (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2022-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Thymic carcinoma is a rare malignant tumor with a poor prognosis. No standard treatment is currently available. The present case was a 64-year-old male smoker with no symptoms referred to our hospital because of abnormal chest radiological findings. The CT study showed a tumor between the anterior m...